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INTRODUCTION
The intracellular protozoan parasite Toxoplasma gondii is a 
ubiquitous pathogen of warm-blooded animals, with approxi-
mately one to 2 billion humans infected worldwide. Further-
more, this parasite can infect and replicate in virtually any nu-
cleated cells, and is able to penetrate several important barriers 
[1]. It causes a large range of clinical manifestations in humans, 
from abortion and congenital infection to eye disease and fatal 
encephalitis [1]. During host cell invasion, T. gondii uses a spe-
cialized set of secretory organelles to inject parasite-derived ef-
fector molecules into host cells. This parasite displays a high 
level of sophistication in its ability to manipulate host respons-
es and their underlying signal transduction cascades [2-5]. Ex-
pression-profiling of a Toxoplasma-infected host transcriptome 
showed a significant change in host gene transcripts as com-
pared with uninfected cells at 24 hr post-infection [2]. Similar-
ly, quantitative analysis of the host proteome during Toxoplas-
ma infection showed that the host cell proteome responded in 
a dramatic way to T. gondii invasion in terms of both expres-
sion levels and protein modifications, revealing a complex and 
intimate molecular relationship between host and parasite [5]. 
Although previous data demonstrated that T. gondii-infected 
cells modulate various molecules including cytokines or che-
mokines [2-5], the transcriptional profiles of host genes after T. 
gondii-infection remain to be elucidated. 
Toxoplasma can modify host cell signaling and cell cycle con-
trol, and also modulates host cell gene expression [5,6]. How-
ever, determining the expression levels of specific genes in in-
termediate hosts after T. gondii infection is not know much. 
Recently, we examined the transcriptional profile of T. gondii-
infected THP-1 macrophages using a cDNA microarray, and 
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Abstract: Toxoplasma gondii can modulate host cell gene expression; however, determining gene expression levels in in-
termediate hosts after T. gondii infection is not known much. We selected 5 genes (ALDH1A2, BEX2, CCL3, EGR2 and 
PLAU) and compared the mRNA expression levels in the spleen, liver, lung and small intestine of genetically different mice 
infected with T. gondii. ALDH1A2 mRNA expressions of both mouse strains were markedly increased at day 1-4 postin-
fection (PI) and then decreased, and its expressions in the spleen and lung were significantly higher in C57BL/6 mice than 
those of BALB/c mice. BEX2 and CCR3 mRNA expressions of both mouse strains were significantly increased from day 
7 PI and peaked at day 15-30 PI (P<0.05), especially high in the spleen liver or small intestine of C57BL/6 mice. EGR2 
and PLAU mRNA expressions of both mouse strains were significantly increased after infection, especially high in the 
spleen and liver. However, their expression patterns were varied depending on the tissue and mouse strain. Taken togeth-
er, T. gondii-susceptible C57BL/6 mice expressed higher levels of these 5 genes than did T. gondii-resistant BALB/c mice, 
particularly in the spleen and liver. And ALDH1A2 and PLAU expressions were increased acutely, whereas BEX2, CCL3 
and EGR2 expressions were increased lately. Thus, these demonstrate that host genetic factors exert a strong impact on 
the expression of these 5 genes and their expression patterns were varied depending on the gene or tissue.
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we selected 5 genes that showed significantly increased mRNA 
expression at more than one timepoint in T. gondii–infected 
THP-1 cells as compared with uninfected cells. The following 
genes were included: ALDH1A2 (aldehyde dehydrogenase1 
family, member A2), BEX2 (brain expressed X-linked 2), CCL3 
(chemokine C-C motif ligand 3), EGR2 (early growth response 
2) and PLAU (plasminogen activator, urokinase). Mice have a 
similar genetic background and immune-related organs as 
compared with humans, which makes them an appropriate 
model for investigation of immune responses and host-patho-
gen interactions against T. gondii [7]. Therefore, to compare the 
mRNA expression profiles of these 5 genes in genetically dif-
ferent mice, T. gondii-resistant BALB/c and T. gondii-susceptible 
C57BL/6 mice were infected with the Me49 strain of T. gondii, 
and mRNA levels of these genes in the spleen, liver, lung and 
small intestine of both mouse strains were determined using 
reverse transcription polymerase chain reaction (RT-PCR).
MATERIALS AND METHODS
Mice
Female 6- to 8-week-old BALB/c (resistant to T. gondii infec-
tion) and C57BL/6 (susceptible to T. gondii infection) mice 
were used. All mice were maintained in pathogen-free condi-
tions within our animal facility. Animal studies were performed 
under the authority of the Chungnam National University An-
imal Ethnics Committee.
Parasites and T. gondii infection 
Cysts of T. gondii strain ME49 were harvested from the 
brains of chronically infected mice. Mice were sacrificed and 
their brains were homogenized in phosphate buffered saline 
(PBS; pH 7.2). Ten microliters of brain suspension was placed 
on a glass slide and the number of cysts was counted in 5 sep-
arate fields of view using a light microscope. For experimental 
infections, BALB/c and C57BL/6 mice were orally inoculated 
with 5 T. gondii Me49 cysts by gavage. 
Preparation of mouse tissues and oligonucleotides
Mice were sacrificed on days 0, 1, 4, 7, 15, and 30 after per-
oral infection with T. gondii ME49. The spleen, liver, lung and 
small intestine from both BALB/c and C57BL/6 mice were re-
moved, washed in PBS, and total RNA was extracted.
We selected 5 genes ALDH1A2, PLAU, BEX2, EGR2, and 
CCL3 from the transcriptional profile of T. gondii-infected 
THP-1 macrophages using a cDNA microarray. These genes 
were shown to have significantly increased mRNA expression 
at more than one time point in T. gondii–infected THP-1 cells 
among 4 times of checking point (1, 4, 6, and 16 hr PI) as 
compared with uninfected cells. To examine the mRNA expres-
sion profiles of 5 genes in the tissues of mice, we prepared oli-
gonucleotide primers specific for each of these 5 genes (Table 
1). Primers for PCR were designed from sequences selected 
from GenBank (National Center for Biotechnology Informa-
tion; http://www.ncbi.nlm.nih.gov) using the Primer3 pro-
gram at an annealing temperature of 60˚C. 
Reverse transcription polymerase chain reaction (RT-
PCR)
Total RNA was extracted from the spleen, liver, lung and 
small intestine of BALB/c and C57BL/6 mice using Trizol re-
agent (Invitrogen, Carlsbad, California, USA), according to the 
manufacturer’s instructions. For RNA extraction, 80-100 mg of 
tissue was cut into small pieces and homogenized in 1 ml of 
Trizol reagent. Homogenized samples were incubated for 5 
min at room temperature (RT), 0.2 ml chloroform was added, 
and the mixture was then incubated for 3 min at RT, followed 
by centrifugation at 12,000×g for 15 min at 4˚C. Isopropyl al-
cohol (0.5 ml) was added to the supernatant to precipitate 
RNA. After washing with 75% ethanol, the RNA pellet was 
dried at RT and resuspended in 100 μl diethyl pyrocarbonate-
treated RNase-free water (DEPC). The concentration and puri-
ty of RNA were determined using a spectrophotometer.
Table 1. Primers sequences used for reverse transcriptase-
polymerase chain reaction (RT-PCR)
Gene 
  name
a
Accession No.   
in GenBank Primer sequence (5`–3`)
b Primer 
size (bp)
ALDH1A2 BC075704.1 F-CCATTGGAGTGTGTGGACAG 380 bp
R-GTCCAAGTCAGCATCTGCAA
PLAU BC120709.1 F-TTGGGGGAGAATTCACTGAG 367 bp
R-GGCAGGCAGATGGTCTGTAT
BEX2 BC027529.1 F-GAAGAAAAGCCACAGGATGC 328 bp
R-AGCTCAGGACTCAGGGCATA
EGR2 BC009093.1 F-TGGGTGTGTGTACCATGTCC 354 bp
R-AGAGAGTGGCGTGAGTGGA
CCL3 BC111443.1 F-ATGAAGGTCTCCACCACTGC 344 bp
R-CTCAAGCCCCTGCTCTACAC
β-actin BC138614 F: TGTTACCAACTGGGACGACA 392 bp
R: TCT CAGCTGTGGTGGTGAAG
aALDH1A2, Aldehyde dehydrogenase1 family, member A2; PLAU, Plas-
minogen activator, Urokinase; BEX2, Brain expressed X-linked 2; EGR2, 
Early growth response 2; CCL3, Chemokine (C-C motif) Ligand 3. 
bF, forward primer sequences; R, reverse primer sequences.  Ismail et al.: mRNA expression of 5 genes in T. gondii-infected mice   9
The cDNA reaction mixture contained the following: 5 μg 
total RNA; 10 pmol oligo (dT)15 primer (Bioneer, Daejon, Ko-
rea), 2 μl; 10× M-MLV RT reaction buffer (0.5 M Tris-HCl; pH 
8.3, 0.75 M KCl, 30 mM MgCl2, 0.1 M DTT, Enzynomics, Dae-
jeon, Korea) 2 μl; 0.25 mM dNTP mixture (TaKaRa, Otsu, Shi-
ga, Japan), 2 μl; ribonuclease inhibitor (20 units, Enzynomics), 
0.25 μl; and M-MLV reverse transcriptase (200 units/μl, Enzy-
nomics), 1 μl. Reverse transcriptase (RT) reactions were incu-
bated for 60 min at 42˚C, and the reaction stopped by incuba-
tion at 70˚C for 10 min. PCR reactions were performed in a 25 
μl volume using 1 μl cDNA as a template, 10× Taq polymerase 
buffer, 2.5 μl; 2.5 mM dNTP, 2 μl; 5` and 3` primers (10 pmol/
μl), 1.5 μl: (Table 1) 10× Taq polymerase, 0.125 μl (Enzynom-
ics); and cDNA template, 1 μl. β-Actin cDNA was used as an 
internal standard. PCR conditions were as follows: 95˚C for 2 
min; followed by 30-35 cycles of denaturation at 95˚C for 40 
sec, annealing at 60˚C for 30 sec, and extension at 72˚C for 30 
sec; followed by a final extension at 72˚C for 10 min. To deter-
mine the necessary number of amplification cycles, we checked 
the amounts of amplification products of each gene at various 
numbers of PCR cycles. The PCR products were increased lin-
early within the numbers of PCR cycle of each gene (30-35 cy-
cles). Twelve microliter of the PCR product were subjected to 
electrophoresis in a 1% agarose gel with 0.5% TBE buffer con-
taining 0.5 g ethidium bromide. A UV transilluminator (Gel 
Doc, Bio-Rad Laboratories Ltd, Hemel, Hempstead, UK) was 
used to visualize PCR products and quantify the band intensi-
ties. 
Statistical analysis
Results are expressed as the mean±standard error (SE) for 
each group. Statistical differences in mRNA expression were 
determined using the Kruskal-Wallis test. Differences among 
the various groups were considered significant when P<0.05.
RESULTS
As shown in Fig. 1, ALDH1A2 mRNA expressions in the 
spleen, liver, lung and small intestine of both mouse strains 
were markedly increased at day 1-4 PI as compared with unin-
fected controls (mRNA expression level was set as 1; P<0.01), 
and decreased thereafter to the basal level at day 15-30 PI. At 
day 1-4 PI, ALDH1A2 mRNA levels in the spleen and lung of 
C57BL/6 mice were significantly higher as compared with 
those of BALB/c mice, however there were not significant dif-
ferences of its expressions between liver and small intestine.
BEX2 mRNA expressions in the spleen, liver, lung and small 
intestine of both mouse strains were significantly increased 
from day 7 PI in comparison to uninfected control and peaked 
at day 15-30 PI, especially high in the spleen and small intes-
tine of C57BL/6 mice (Fig. 2). BEX2 mRNA expressions in the 
spleen and small intestine were significantly higher in the 
C57BL/6 mice than those of BALB/c mice, however there were 
not significant differences of BEX2 expressions in the liver and 
lung between both mouse strains. 
CCL3 mRNA expressions in the spleen, liver, lung and small 
intestine of both mouse strains were significantly increased 
from 7-15 days after T. gondii infection as compared to unin-
Day 0
BALB/c C57BL/6
B1 C1 B2 C2 B3 C3 B4 C4
Day 1
Day 4
Day 7
Day 15
Day 30
β-actin
7
6
5
4
3
2
1
0
R
e
l
a
t
i
v
e
 
m
R
N
A
 
e
x
p
r
e
s
s
i
o
n
s
B-spleen C-spleen B-liver C-liver B-lung C-lung B-intestine C-intestine
Day 1
Day 4
Day 7
Day 15
Day 30 A B
Fig. 1. ALDH1A2 mRNA expressions in the various tissues of mice infected with cyst of Me49 strain of Toxoplasma gondii. (A) Cellu-
lar RNA was then extracted, and the mRNA expression of ALDH1A2 was analysed by RT-PCR, (B) Kinetics of mRNA expression of 
AHDH1A2. Data are presented as mean±SE of 5 mice per group and are representative of 2 separate experiments. B1-4; spleen, 
liver, lung and small intestine of T. gondii-infected BALB/c mice, respectively. C1-4; spleen, liver, lung and small intestine of T. gondii-
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fected control, and then peaked at day 30 PI (P<0.05), and its 
expressions in the spleen and liver were prominently high (Fig. 
3). CCL3 mRNA expressions in the small intestine were signif-
icantly higher in C57BL/6 mice as compared to that of BALB/c 
mice, however its expressions in the spleen, liver or lung were 
not significantly different from each mouse strain.
As shown in Fig. 4, EGR2 mRNA expressions in the spleen 
and lung of both mouse strains were gradually increased after 
T. gondii infection, and peaked at day 30 PI (P<0.01). However 
EGR2 expression patterns were different in the liver and small 
intestine between BALB/c and C57BL/6 mice. EGR2 mRNA 
expressions in the liver of BALB/c mice was initially low and 
peaked at day 15 or 30 PI (P<0.01), whereas its expression in 
C57BL/6 mice were markedly high at day 1 PI and decreased 
thereafter (P<0.01). EGR2 mRNA expression in the small in-
testine of BALB/c mice was peaked at day 1 PI (P<0.01) and 
then decreased gradually to the basal, whereas its expression 
of C57BL/6 mice were significantly increased from day 7 PI 
and peaked at day 30 PI. 
PLAU mRNA expressions in the spleen and liver of BALB/c 
mice were significantly increased from day 7 PI as compared 
with those of uninfected control (P<0.05) and peaked at day 
15-30 PI, however its expressions in C57BL/6 mice were peaked 
at day 1 (P<0.01), and then abruptly decreased. PLAU mRNA 
expressions did not change significantly in the lung of both 
mouse strains during experimental period (Fig. 5). PLAU 
mRNA expression in the small intestine of BALB/c and C57BL/ 
6 mice were peaked at day 1 PI (P<0.01) and then decreased 
(P<0.01).
Day 0
BALB/c C57BL/6
B1 C1 B2 C2 B3 C3 B4 C4
Day 1
Day 4
Day 7
Day 15
Day 30
β-actin
7
6
5
4
3
2
1
0
R
e
l
a
t
i
v
e
 
m
R
N
A
 
e
x
p
r
e
s
s
i
o
n
s
B-spleen C-spleen B-liver C-liver B-lung C-lung B-intestine C-intestine
Day 1
Day 4
Day 7
Day 15
Day 30
Fig. 3. CCL3 mRNA expressions in the various tissues of mice infected with cyst of Me49 strain of T. gondii. (A) Cellular RNA was 
then extracted, and the mRNA expression of CCL3 was analyzed by RT-PCR, (B) Kinetics of mRNA expression of CCL3. Data are 
presented as mean±SE of 5 mice per group and are representative of 2 separate experiments.
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Fig. 2. BEX2 mRNA expressions in the various tissues of mice infected with cyst of Me49 strain of T. gondii. (A) Cellular RNA was 
then extracted, and the mRNA expression of BEX2 was analyzed by RT-PCR, (B) Kinetics of mRNA expression of BEX2. Data are 
presented as mean±SE of 5 mice per group and are representative of 2 separate experiments.
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DISCUSSION
Host genetic factors strongly determine the course of various 
infectious diseases. BALB/c mice are known to be genetically 
resistant to T. gondii infection, whereas C57BL/6 mice are sus-
ceptible [8]. We evaluated the role of host genetic factors on 
the expressions of ALDH1A2, BEX2, EGR2, CCL3 and PLAU 
genes in various mouse tissues. Five gene mRNA expression 
levels were higher in T. gondii-infected C57BL/6 mouse as 
compared with BALB/c mouse, especially high in the spleen 
and liver. And ALDH1A2 and PLAU expression were increased 
acutely, whereas BEX2, CCL3 and EGR2 expressions were in-
creased lately. Thus, these demonstrate that host genetic factors 
exert a strong impact on the expression of these 5 genes in a 
murine model and their expression patterns were varied de-
pending on the gene or tissue.
Host cell transcription is a major process affected by infec-
tion, and changes in gene expression occur at various times 
following infection [2,3,9]. The EGR1 and EGR2 genes are 
well-known immediate early response genes in growth factor-
stimulated cells and encode transcription factors that regulate 
cell survival and growth [10]. In this study, EGR2 mRNA ex-
pression was rapidly upregulated in both strains of mice after 
T. gondii infection, especially high in the spleen and small in-
testine of T. gondii-infected C57BL/6 mouse as compared with 
those of BALB/c mice. These results are similar to previous 
studies suggesting that EGR1 and EGR2 transcription factors, 
as well as their downstream targets, were rapidly upregulated 
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Fig. 4. EGR2 mRNA expressions in the various tissues of mice infected with cyst of Me49 strain of Toxoplasma gondii. (A) Cellular 
RNA was then extracted, and the mRNA expression of EGR2 was analyzed by RT-PCR, (B) Kinetics of mRNA expression of EGR2. 
Data are presented as mean±SE of 5 mice per group and are representative of 2 separate experiments.
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Fig. 5. PLAU mRNA expressions in the various tissues of mice infected with cyst of Me49 strain of T. gondii. (A) Cellular RNA was 
then extracted, and the mRNA expression of PLAU was analyzed by RT-PCR, (B) Kinetics of mRNA expression of PLAU. Data are 
presented as mean±SE of 5 mice per group and are representative of 2 separate experiments.
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in Toxoplasma-infected cells [2,11], and that T. gondii increases 
the activity of transcription factors, including STAT3/6, hypoxia 
inducible factor and EGR2 [12]. Both our work and previous 
studies demonstrate that viable T. gondii acts as a powerful in-
ducer of the transcriptional factor EGR2, especially in C57BL/6 
mice, but the generated expression patterns differ from those 
induced by host factors. 
ALDH1A2 is the primary enzyme responsible for the syn-
thesis of retinoic acid (RA) from retinaldehyde. RA, the active 
derivative of vitamin A (retinol), is a signaling molecule that 
plays a major role in regeneration and differentiation in nor-
mal and disease states [13]. BEX2 belongs to the brain-ex-
pressed X-linked gene family and is known to play a role in 
cell cycle progression and neuronal differentiation [14], and it 
regulates mitochondrial apoptosis and G1 cell cycle in breasr 
cancer [15]. In this study, ALDH1A2 and BEX2 mRNA expres-
sions in both mouse strains were upregulated after infection, 
and its expression was higher in C57BL/6 than BALB/c mice, 
especially in the spleen and small intestine. These data suggest 
that high production of ALDH1A2 and BEX2 mRNA in the 
spleen and small intestine of C57BL/6 mice may be related to 
a mechanism to compensate the pathophysiological changes 
such as apoptosis after T. gondii infection [13].
PLAU encodes a serine protease involved in degradation of 
the extracellular matrix. PLAU protein is capable of converting 
plasminogen to plasmin and plays a key role in cell adhesion, 
migration, and proliferation [16]. In the current study, PLAU 
mRNA expression levels were higher in C57BL/6 mice than 
those of BALB/c mice, especially high in the spleen and liver. 
These phenomena indicate that T. gondii-infected C57BL/6 
mice may induce more tissue reactions such as inflammation, 
thrombolysis, wound healing, and tissue regeneration than in 
BALB/c mice [17].
CCL3 is produced by several types of immune cells and glial 
cells and selectively promotes adhesion and chemotaxis of 
various leukocyte subtypes [18]. We observed that CCL3 mRNA 
expression was significantly increased in both mouse strains 
after T. gondii infection, and was especially high in the spleen, 
liver and small intestine of C57BL/6 mice. Previous studies 
demonstrated that mRNA expression levels of CCL2, CCL3, 
CCL5, CXCL2, CXCL9 and CXCL10 were significantly increased 
on day 8 PI in freshly isolated IECs collected from T. gondii-in-
fected mice [19], and T. gondii triggered neutrophil synthesis of 
CCL3, CCL4, CCL5, and CCL20 [20]. Both our and previous 
data suggest that CCL3 is strongly expressed in mice after T. 
gondii infection; however, its expression was higher in a sus-
ceptible mouse strain.
Here, we evaluated the mRNA expression profile of AL-
DH1A2, BEX2, CCL3, EGR2, and PLAU genes to identify the 
impact of host genetic factors in T. gondii infection. Levels of 
mRNA expressions were high in the spleen, liver and small in-
testine of C57BL/6 mice; however, mRNA expressions in the 
lung of BALB/c mice were low. High expression of these genes 
in T. gondii-infected C57BL/6 mice may serve as a compensa-
tory mechanism, preventing the pathophysiologic consequenc-
es of T. gondii infection. Thus, our data demonstrate that host 
genetic factors exert a strong impact on the expression of cer-
tain genes in tissue- and gene-specific manners, which allow 
the host to resist parasite infection.
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